source
- Podcast explores emerging rapid‑acting and psychedelic therapies for treatment‑resistant depressionIn a recent episode of BioSpace’s Denatured podcast, host Jennifer C. Smith‑Parker talks with Hans Eriksson, chief medical officer of FundaMental Pharma, and Steve Levine, chief patient officer at…
- Tiziana Life Sciences CEO Ivor Elrifi buys 321,423 shares, raising his stake to 4.79 millionTiziana Life Sciences announced that its chief executive, Ivor Elrifi, purchased 321,423 common shares of the company on NASDAQ at $1.00 per share. The transaction brings Elrifi’s total ownership…